Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Account Payables: 2019-2023

Historic Change in Account Payables for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2023 value amounting to $6.6 million.

  • ADC Therapeutics' Change in Account Payables rose 2016.87% to $6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year increase of 923.55%. This contributed to the annual value of $2.5 million for FY2024, which is 22.41% down from last year.
  • As of Q4 2023, ADC Therapeutics' Change in Account Payables stood at $6.6 million, which was up 342.38% from -$2.7 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Account Payables ranged from a high of $6.8 million in Q4 2021 and a low of -$3.7 million during Q1 2023.
  • For the 3-year period, ADC Therapeutics' Change in Account Payables averaged around $856,750, with its median value being $3,726 (2021).
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Change in Account Payables showed a top increase of 87,296.02% in 2023 and a maximum decrease of 196,207.02% in 2023.
  • ADC Therapeutics' Change in Account Payables (Quarterly) stood at -$3.4 million in 2019, then reached $5.3 million in 2020, then plummeted by 99.89% to $6.8 million in 2021, then crashed by 95.43% to $310,411 in 2022, then spiked by 2,016.87% to $6.6 million in 2023.
  • Its Change in Account Payables stands at $6.6 million for Q4 2023, versus -$2.7 million for Q3 2023 and $3.0 million for Q2 2023.